Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Oligodendroglioma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Astrocytoma 1Advanced Breast Cancer 1

Interventions

Tamoxifen 3Neoadjuvant Therapy 2Amplified Fragment Length Polymorphism Analysis 2Ultrasonography 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mammography 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Immunoenzyme Techniques 1Fulvestrant 1DNA Methylation 1Chemotherapy, Adjuvant 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Intraductal, Noninfiltrating × In Situ Hybridization, Fluorescence × Clear all
NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

National Cancer Institute (NCI)

Phase NA Unknown
30 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡